Crinetics Pharmaceuticals Inc CRNX

NAS: CRNX | ISIN: US22663K1079 30/04/2025

33,39 USD (+0,24%)

(+0,24%) 30/04/2025

Grafiek Crinetics Pharmaceuticals Inc

Grafiek Crinetics Pharmaceuticals Inc

1 dag1d 0,24%
1 week1w 0,00%
1 maand1m 9,05%
3 maanden3m -13,92%
6 maanden6m -41,10%
1 jaar1j -25,88%
5 jaar5j 104,60%

donderdag 8 mei 2025, 22:00

Kwartaalcijfers (1ste kwartaal)

Crinetics Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

12 maart 2021 · Crinetics Pharmaceuticals Showcasing Breadth of Pipeline at ENDO 2021 with Presentations on Three Clinical Programs · Persbericht

4 februari 2021 · Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study · Persbericht

3 februari 2021 · Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study · Persbericht

6 januari 2021 · Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Crinetics Pharmaceuticals Inc

Gezondheidstechnologie

Website: www.crinetics.com

Hoofdzetel: San Diego, California Verenigde Staten

CEO: R. Scott Struthers

Werknemers: 194

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe